The prognosis of proliferative diabetic retinopathy (PDR) is greatly improved in the era of panretinal photocoagulation and anti-vascular endothelial growth factor (VEGF) intravitreal injection [1,2]. This evidence concerns the gene VEGFA and proliferative diabetic retinopathy.